Search clinical trials for: Complicated intra-abdominal infections

Total 56704 results

University of Calgary
Alberta Health services; 3M

Active, not recruiting

Peritoneal Vacuum Therapy to Reduce Inflammatory Response From Abdominal Sepsis/Injury (SAD)

Intra-abdominal Hypertension | Abdominal Compartment Syndrome

Canada
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections

cUTI

United States, Latvia, Poland, Czechia, Romania, Ukraine, Russian Federation, Georgia, Colombia, Bulgaria, Estonia, Greece, Hungary, Israel, Italy, Mexico, Moldova, Republic of, South Africa
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections (IGNITE1)

Complicated Intra-abdominal Infections

United States, France, Ukraine, Argentina, Bulgaria, Romania, South Africa, Germany, Estonia, Russian Federation, Lithuania, Czechia, Latvia
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections (IGNITE3)

Complicated Urinary Tract Infections

Ukraine, United States, Bulgaria, Romania, Estonia, Russian Federation, Hungary, Austria, Slovakia, Latvia, Moldova, Republic of, Georgia
Tetraphase Pharmaceuticals, Inc.

Completed

Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections

Complicated Intra-abdominal Infection

United States, Latvia, Lithuania, Romania, India, Bulgaria
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections (IGNITE4)

Complicated Appendicitis | Complicated Intra-abdominal Infections

Ukraine, United States, Bulgaria, Romania, Estonia, Russian Federation, Lithuania, Hungary, Latvia, Georgia, Czechia
Centro Hospitalar do Tâmega e Sousa

Completed

Inflammatory Parameters as Predictive Factors for Complicated Appendicitis

Acute Appendicitis
Novartis Pharmaceuticals

Terminated

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)

Intra-abdominal Infections

United States
National Taiwan University Hospital

Completed

Complicated Appendicitis in COVID-19 Era

Covid19 | Complicated Appendicitis
Haramaya Unversity

Completed

Causes of Complicated Appendicitis at Referral Hospital (AA)

Complicated Appendicitis

Ethiopia
Universidad Nacional de Colombia

Completed

Cefuroxime Resistance in Pyelonephritis

Urinary Tract Infections

Colombia
Ziauddin University

Completed

Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children ([XDRTYPHOID])

Typhoid Fever

Pakistan
University of Leeds
The Leeds Teaching Hospitals NHS Trust

Completed

CABI: Antibiotic Duration for Complicated Intra-ABdominal Infection (CABI)

Complicated Intraabdominal Infections

United Kingdom
HaEmek Medical Center, Israel

Completed

Acute Appendicitis in Foreign Workers of Northern Israel

Surgery

Israel
Paratek Pharmaceuticals Inc
Novartis Pharmaceuticals

Terminated

Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) (CSSI)

Skin Diseases, Infectious

United States
Meir Medical Center

Completed

the Impact of COVID-19 Pandemic on the Incidence and Outcome of Complicated Appendicitis

Covid19 | Appendicitis

Israel
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Complicated Intra-abdominal Infection | Complicated Urinary Tract Infection

Japan
Theravance Biopharma

Completed

TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection

Staphylococcal Skin Infection

United States
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess (MICA)

CD

France
Shionogi

Completed

Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens (CREDIBLE - CR)

Sepsis | Bloodstream Infections (BSI) | Hospital Acquired Pneumonia (HAP) | Complicated Urinary Tract Infection (cUTI) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)

United States, Brazil, Croatia, France, Germany, Greece, Guatemala, Israel, Italy, Japan, Korea, Republic of, Spain, Taiwan, Thailand, Turkey, United Kingdom
Rambam Health Care Campus
Hillel Yaffe Medical Center

Completed

Patient Time and In-hospital Delay of Surgery Association With Complicated Appendicitis

Acute Appendicitis
Iterum Therapeutics, International Limited

Completed

Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults

Complicated Urinary Tract Infections

United States, Estonia, Hungary, Georgia, Latvia
National Institute of Allergy and Infectious Diseases...

Terminated

Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)

Urinary Tract Infection

United States
Iterum Therapeutics, International Limited

Completed

Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)

Intra Abdominal Infections

United States, Bulgaria, Estonia, Georgia, Hungary, Latvia, Poland
Jianbo Yu

Unknown

Study of Biomarkers in Patients of Sepsis Complicated With Gastrointestinal Dysfunction

Sepsis | Gastrointestinal Dysfunction

China
Turku University Hospital
Oulu University Hospital; Kuopio University Hospital; Seinajoki Central Hospital and other collaborators

Active, not recruiting

Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis (APPACII)

Acute Appendicitis

Finland
Turku University Hospital
Helsinki University Central Hospital; Oulu University Hospital; Kuopio University... and other collaborators

Enrolling by invitation

Acute Appendicitis and Microbiota - Etiology of Appendicitis and Antibiotic Therapy Effects (MAPPAC)

Acute Appendicitis

Finland
Turku University Hospital
Helsinki University Central Hospital; Oulu University Hospital; Kuopio University... and other collaborators

Enrolling by invitation

Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis (APPACIII)

Acute Appendicitis

Finland
Ain Shams University

Unknown

D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia

Coronavirus Disease (COVID)19

Egypt
Paratek Pharmaceuticals Inc

Completed

Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Infectious Skin Disease | Bacterial Skin Disease

United States
Sihuan Pharmaceutical Holdings Group Ltd.

Completed

A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Complicated Urinary Tract Infection Including Acute Pyelonephritis

China
Sihuan Pharmaceutical Holdings Group Ltd.

Completed

Pharmacokinetics of Benapenem in Subjects With Renal Impairment

Complicated Urinary Tract Infection; Cuti

China
Institute of Tropical Medicine, Belgium
University of Gondar; Boru Meda Hospital

Completed

Outcomes of Complicated CL in Ethiopia Treated With Miltefosine

Cutaneous Leishmaniases

Ethiopia
Pfizer
Innovative Medicines Initiative (IMI) COMBACTE-CARE

Completed

Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)

Complicated Intra-Abdominal Infections, cIAIs

Spain, France, Germany
Chongqing Medical University

Withdrawn

Prognositc Factors in COVID-19 Patients Complicated With Hypertension

2019-nCoV

China
The Second Hospital of Nanjing Medical University

Withdrawn

Washed Microbiota Transplantation for Patients With 2019-nCoV Infection

COVID-19 Complicated With Refractory Intestinal Infections

China
Allecra
Medpace, Inc.

Completed

Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections

Urinary Tract Infections

United States, Serbia, Hungary, Estonia, South Africa, Belarus, Poland, Ukraine, Argentina, Bulgaria, Croatia, Georgia, Latvia, Lithuania, Mexico, Peru, Russian Federation, Slovakia, Spain
Entasis Therapeutics

Completed

Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections

Acute Pyelonephritis | Complicated Urinary Tract Infection

Bulgaria
Shionogi

Completed

A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections (APEKS-cUTI)

Urinary Tract Infections
Trius Therapeutics LLC

Completed

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

Skin Diseases, Infectious | Skin Diseases, Bacterial

United States
Fundación Pública Andaluza para la gestión de la...

Unknown

Efficacy of Intravenous Fosfomycin in the Treatment of Complicated Urinary in Real-life Conditions.

Complicated Urinary Tract Infection

Spain
Venus Remedies Limited

Completed

CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria (PLEA)

Acute Pyelonephritis | Urinary Tract Infection Complicated

India
Cubist Pharmaceuticals LLC

Completed

Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)

Skin Diseases, Infectious | Skin Diseases, Bacterial
The Hospital for Sick Children

Terminated

Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study

Intra-abdominal Abscess

Canada
Merck Sharp & Dohme LLC

Completed

Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)

Intra-abdominal Infections
Michael Cohen-Wolkowiez
The Emmes Company, LLC

Completed

Antibiotic Safety (SCAMP) (SCAMP)

Complicated Intra Abdominal Infections

United States, Canada
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003)

Urinary Tract Infections | Pyelonephritis
Centre Hospitalier Universitaire de Nīmes

Completed

Multicentre Observational Study on Community Acquired Intraabdominal Infections Management (PERICOM)

Intraabdominal Infections

France
Nabriva Therapeutics AG
Medpace, Inc.

Completed

Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections (ZEUS)

Acute Pyelonephritis | Urinary Tract Infection Complicated | Urinary Tract Infection Symptomatic

Poland, Ukraine, Belarus, Bulgaria, Romania, Greece, United States, Russian Federation, Hungary, Lithuania, Slovakia, Czechia, Latvia, Croatia, Georgia, Estonia
Rempex (a wholly owned subsidiary of Melinta Therapeutics...
Department of Health and Human Services

Completed

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Bacteremia | Acute Pyelonephritis | Ventilator-associated Bacterial Pneumonia | Urinary Tract Infection Complicated | Hospital Acquired Bacterial Pneumonia | Abdominal Infection

Italy, United States, Colombia, Greece, Israel, Brazil, Argentina, United Kingdom

Search clinical trials for: Complicated intra-abdominal infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations